REPLIGEN CEO Loeillot Olivier forfeited 2,842 shares at $169.61 per share on Sep 3, 2026, then sold 3,035 shares at $165.90 per share on Sep 4, 2026. For investors, the reported ownership balances moved from 51,404 shares after the forfeiture to 48,369 shares after the sale.
Key Highlights
- The forfeiture carried SEC transaction code F.
- Olivier later sold 3,035 shares at $165.90 per share.
- Olivier owned 48,369 shares after the sale.
REPLIGEN CORP (NASDAQ: RGEN) Chief Executive Officer Loeillot Olivier forfeited 2,842 shares at $169.61 per share on Sep 3, 2026. Olivier then sold 3,035 REPLIGEN CORP shares at $165.90 per share on Sep 4, 2026.
CEO Forfeiture and Subsequent Sale
Olivier’s reported ownership following that transaction was 51,404 shares. After the sale, Olivier’s reported holding was 48,369 shares.
Reported Ownership After Both Transactions
The stated ownership balance was 51,404 shares after the forfeiture and 48,369 shares after the subsequent sale. The two entries therefore show different transaction types within consecutive reporting dates. The first carried SEC transaction code F, while the second carried SEC transaction code S. Both transactions involved REPLIGEN CORP shares held by its chief executive officer.
FAQs
Q: How many REPLIGEN shares did CEO Loeillot Olivier forfeit?
A: Loeillot Olivier forfeited 2,842 REPLIGEN CORP shares on Sep 3, 2026. The transaction was priced at $169.61 per share and carried SEC code F.
Q: What happened to RGEN insider ownership after the transactions?
A: Olivier’s reported REPLIGEN ownership was 51,404 shares after the forfeiture. It stood at 48,369 shares after the subsequent sale of 3,035 shares.
Q: Did the REPLIGEN CEO also sell shares?
A: Yes. Olivier sold 3,035 REPLIGEN CORP shares at $165.90 per share on Sep 4, 2026, in a transaction classified under SEC code S.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.